Cypress Asset Management Inc Amgen Inc Transaction History

Cypress Asset Management Inc

$357 Million
Q1 2024

A detailed history of Cypress Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Cypress Asset Management Inc holds 4,277 shares of AMGN stock, worth $1.12 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

4,277

Previous 3,722 14.91%

Holding current value

$1.12 Million

Previous $1.07 Million 13.43%

% of portfolio

0.34%

Previous 0.33%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 11, 2024	BUY	$268.87 - $324.56 $149,222 - $180,130	555 Added 14.91%	4,277 $1.22 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $2,557 - $2,884	10 Added 0.27%	3,722 $1.07 Million
Q3 2023 Feb 09, 2024	BUY	$218.65 - $271.46 $3,279 - $4,071	15 Added 0.4%	3,737 $1 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $31,069 - $36,738	145 Added 4.07%	3,712 $824,000
Q1 2023 May 25, 2023	BUY	$225.79 - $275.2 $6,773 - $8,256	30 Added 0.85%	3,567 $862,000
Q4 2022 Feb 28, 2023	SELL	$229.03 - $291.01 $17,177 - $21,825	-75 Reduced 2.08%	3,537 $928,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $19,079 - $21,517	-85 Reduced 2.3%	3,612 $814,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $42,681 - $47,496	-185 Reduced 4.77%	3,697 $899,000
Q1 2022 Jun 06, 2022	SELL	$219.27 - $242.57 $233,522 - $258,337	-1,065 Reduced 21.53%	3,882 $939,000
Q4 2021 Jan 31, 2022	SELL	$198.88 - $227.6 $445,690 - $510,051	-2,241 Reduced 31.18%	4,947 $1.11 Million
Q3 2021 Oct 18, 2021	SELL	$212.27 - $248.7 $131,607 - $154,194	-620 Reduced 7.94%	7,188 $1.53 Million
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $576,942 - $640,075	-2,470 Reduced 24.03%	7,808 $1.9 Million
Q1 2021 Apr 22, 2021	SELL	$221.91 - $258.6 $212,811 - $247,997	-959 Reduced 8.53%	10,278 $2.56 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $18,392 - $21,901	-85 Reduced 0.75%	11,237 $2.58 Million
Q3 2020 Oct 26, 2020	SELL	$234.65 - $260.95 $10,324 - $11,481	-44 Reduced 0.39%	11,322 $2.88 Million
Q2 2020 Jul 28, 2020	SELL	$197.81 - $242.74 $99,894 - $122,583	-505 Reduced 4.25%	11,366 $2.68 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $1,822 - $2,417	-10 Reduced 0.08%	11,871 $2.41 Million
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $105,957 - $136,192	-560 Reduced 4.5%	11,881 $2.86 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $17,411 - $20,862	-100 Reduced 0.8%	12,441 $2.41 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $56,677 - $66,439	340 Added 2.79%	12,541 $2.31 Million
Q1 2019 Apr 29, 2019	BUY	$180.87 - $203.88 $1.99 Million - $2.24 Million	11,001 Added 916.75%	12,201 $2.32 Million
Q3 2018 Oct 19, 2018	SELL	$185.29 - $208.89 $1,852 - $2,088	-10 Reduced 0.83%	1,200 $249,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $23,720 - $27,720	-140 Reduced 10.37%	1,210 $206,000
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $2,531 - $2,828	-15 Reduced 1.1%	1,350 $235,000
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $228,350 - $260,715	1,365	1,365 $255,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Asset Management Inc with notifications on news.

Account

Cypress Asset Management Inc Amgen Inc Transaction History